SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-22-224174
Filing Date
2022-08-18
Accepted
2022-08-18 16:48:35
Documents
16
Period of Report
2022-07-29
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d391157d8ka.htm   iXBRL 8-K/A 32234
2 EX-99.1 d391157dex991.htm EX-99.1 330777
3 EX-99.2 d391157dex992.htm EX-99.2 111076
4 EX-99.3 d391157dex993.htm EX-99.3 228542
  Complete submission text file 0001193125-22-224174.txt   959316

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bcacu-20220729.xsd EX-101.SCH 4541
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcacu-20220729_def.xml EX-101.DEF 14735
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcacu-20220729_lab.xml EX-101.LAB 24720
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcacu-20220729_pre.xml EX-101.PRE 15828
10 EXTRACTED XBRL INSTANCE DOCUMENT d391157d8ka_htm.xml XML 6424
Mailing Address 75 SHOREWAY ROAD, SUITE C SAN CARLOS CA 94070
Business Address 75 SHOREWAY ROAD, SUITE C SAN CARLOS CA 94070 650.931.6236
Apexigen, Inc. (Filer) CIK: 0001814140 (see all company filings)

IRS No.: 851260244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39488 | Film No.: 221177974
SIC: 2834 Pharmaceutical Preparations